839 results found.
FDA Approves Investigational Device Exemption for Agili-C Implant
CartiHeal received FDA approval of its Investigational Device Exemption application submitted for the A...
Anika Gains CE Mark Approval for ORTHOVISC-T
Anika Therapeutics received CE Mark approval for ORTHOVISC®-T injection indicated to relieve pain and rest...
Study Results: InSpace in the Treatment of Massive Rotator Cuff Tears
Initial study results indicate that patients undergoing the InSpace™ procedure to treat massive rotator cuff tear...
Vericel's Proposed Public Offering of Common Stock
Vericel intends to sell shares of common stock in an underwritten public offering.
Study Results: OrthoTrophix TPX-100 in Knee OA
OrthoTrophix announced results of the first proof of principle study of TPX-100 in bilateral knee osteoar...
Zimmer Biomet Updates: Product Supply Matters, Form 483
Zimmer Biomet reports that most product lines impacted by previously-disclosed shipping delays have returned to full ...
FDA Approves Vericel's MACI for Treatment of Adult Symptomatic Knee Cartilage Defects
FDA approved Vericel's MACI® for the repair of adult symptomatic single or multiple full-thickness cartilage defects
New DUROLANE Agreement
Bioventus entered into an agreement with Galderma to bring DUROLANE knee osteoarthritis treatment to the U.S.
Jury Finds in Favor of Arthrex vs. Smith & Nephew
Arthrex was granted US $17MM+ in damages following a jury finding of willful infringement by Smith & Neph...
Strategic orthopaedic-related 510(k)s issued in November 2016
Strategic orthopaedic-related 510(k)s issued in November 2016 include: Preference Elite Pedicle Screw System (Amedica); Titanium Porous Fixat...
International Cartilage Repair Society Launches Global Patient Registry
The International Cartilage Repair Society launched what is claimed as the first global, web-based patient registry offering an
OrthoSpace Closes $7 Million Equity Financing Round
OrthoSpace closed a US $7MM equity financing round. Funds will support an ongoing U.S. IDE study and ex-U.S. commercia...
MinInvasive Update: New Financing, Strategic Partnership with MicroPort Scientific
MinInvasive, developer of the OmniCuff™ for rotator cuff repair, entered into a strategic partnership...
Zimmer Biomet Launches Comprehensive Vault Reconstruction, a Patient-matched Glenoid Implant
Zimmer Biomet introduced the Comprehensive® Vault Reconstruction System, reported to be the first patie...
Company Revenue 3Q16: A Final Look
By Julie A. Vetalice As we wrap up orthopaedic revenue for the latest reporting period, we observe that Stryker and Zimmer Biomet lead the largest orthopaedic companies in 3Q16 growth:
Tegra Medical to be Acquired by SFS
Tegra Medical, a contract manufacturer of orthopaedic implants and instruments, is to be acquired by SFS Group, a provider of...
Bioventus Launches DUROLANE in Mexico
Bioventus launched DUROLANE® single-injection joint fluid therapy in Mexico, indicated for treatment of mild to ...
Limited Launch of KATOR Suture Anchor
KATOR commenced limited launch of its KATOR Suture Anchor system and has completed the first surgical case.
Fidia's HYMOVIS Receives Product-Specific J-Code
CMS assigned a unique HCPCS reimbursement code to Fidia Pharma's HYMOVIS® highly viscoelastic, non-crosslinked hydro...
Vericel Reports 3Q16 Revenue
Vericel posted 3Q16 Carticel revenue of US $8.3MM, +7.8% vs. 3Q15. Carticel is an autologous chondrocyte implant marketed in the ...
CollPlant Signs Exclusive Distribution Agreement with Arthrex for Vergenix STR
CollPlant signed an exclusive ex-U.S. distribution agreement with Arthrex for Vergenix™
Seikagaku Enters U.S. Distribution Agreement with Zimmer Biomet for VISCO-3
Seikagaku entered into an exclusive agreement with Zimmer Biomet for U.S. distribution of VISCO-3
KATOR Receives FDA Clearance for Knotless Suture Anchor
KATOR received a second FDA 510(k) clearance for the KATOR suture anchor, expanding the system for use with 2mm ...
Smith & Nephew Reports 3Q16 Revenue
ORTHOWORLD estimates Smith & Nephew 3Q16 orthopaedic revenue of US $760.0MM, +2.8% from 3Q15. 
Wright Medical Reports 3Q16 Revenue
Wright Medical reported 3Q16 revenue of US $157.3MM, +8.7% from 3Q15. (U.S. $118.1MM, +11.1%; ex-U.S. $39.3MM, +2.0%
  • 8401 Chagrin Road, Suite 18
  • Chagrin Falls, Ohio 44023 USA
  • Phone: 440.543.2101 • Fax: 440.543.2122
  • ©1992-2018 ORTHOWORLD
  • All Rights Reserved.
  • Site Managed By:
  • Open Professional Group